| P50 | author | Dieter Buchheidt | Q40279734 |
| | Werner J. Heinz | Q42958840 |
| | Maximilian Christopeit | Q56993882 |
| P2093 | author name string | S Hähnel | |
| | S Schwartz | |
| | H H Wolf | |
| | M Ruhnke | |
| | E Schalk | |
| | G Maschmeyer | |
| | M Schmidt-Hieber | |
| | J Panse | |
| | O Penack | |
| | U Meyding-Lamadé | |
| | G Silling | |
| P2860 | cites work | Corticosteroids for acute bacterial meningitis | Q24202288 |
| | Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group | Q24519019 |
| | Comparison of nested PCR and real time PCR of Herpesvirus infections of central nervous system in HIV patients | Q24804134 |
| | Progressive multifocal leukoencephalopathy: current treatment options and future perspectives | Q26776236 |
| | Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab | Q26851341 |
| | Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review | Q28087309 |
| | Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 |
| | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
| | Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America | Q28272494 |
| | Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial | Q28278518 |
| | Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis | Q30431534 |
| | Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation | Q30604692 |
| | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 |
| | Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: a prospective cohort study | Q33260257 |
| | Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project | Q33383576 |
| | PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids | Q33398308 |
| | Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi | Q33588561 |
| | Clinical review: Efficacy of antimicrobial-impregnated catheters in external ventricular drainage - a systematic review and meta-analysis | Q33751899 |
| | Meningitis in pediatric cancer patients: a review of forty cases from a single institution | Q33756659 |
| | Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis | Q33893285 |
| | Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system | Q33908389 |
| | Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification | Q33966960 |
| | JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy | Q45751488 |
| | Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations | Q45762873 |
| | JC virus DNA in cerebrospinal fluid of human immunodeficiency virus—infected patients: Predictive value for progressive multifocal leukoencephalopathy | Q45786584 |
| | Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis | Q45834975 |
| | Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation | Q45867015 |
| | Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). | Q45945768 |
| | A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. | Q46012365 |
| | Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. | Q46032042 |
| | Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess | Q46070946 |
| | Bacterial meningitis: rapid diagnosis and microbial profile: a multicentered study | Q46081064 |
| | Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. | Q46083230 |
| | Azole-resistant central nervous system aspergillosis. | Q46094844 |
| | Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole | Q46124302 |
| | Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q46156632 |
| | Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet | Q46207466 |
| | Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis | Q46248271 |
| | Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis | Q46336266 |
| | Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis | Q46406633 |
| | Treatment of Candida infections with amphotericin B lipid complex | Q46421806 |
| | Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis | Q46495013 |
| | Improved outcome in central nervous system aspergillosis, using voriconazole treatment | Q46585075 |
| | Brain stem candidiasis mimicking cerebellopontine angle tumor | Q46723155 |
| | Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature | Q46853032 |
| | Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis | Q46979014 |
| | Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples | Q47655061 |
| | Diffusion-weighted imaging in brain aspergillosis. | Q48091761 |
| | Molecular diagnosis of cerebral aspergillosis by sequence analysis with panfungal polymerase chain reaction | Q48099857 |
| | Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. | Q48110777 |
| | Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay | Q48128644 |
| | Opportunistic CNS infection after bone marrow transplantation | Q48177382 |
| | Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients | Q48201029 |
| | Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant | Q48364331 |
| | Vidarabine versus acyclovir therapy in herpes simplex encephalitis | Q48385636 |
| | Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma | Q48431474 |
| | Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia | Q48579058 |
| | Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients | Q48621181 |
| | Posaconazole responsive cerebral aspergillosis in an immunocompetent adult | Q48710909 |
| | High-dose itraconazole for the treatment of cerebral aspergillosis | Q48878544 |
| | Successful isavuconazole salvage therapy in a patient with invasive mucormycosis | Q48878630 |
| | Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors | Q50108387 |
| | A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. | Q50519159 |
| | Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy. | Q51169777 |
| | A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid. | Q51185856 |
| | Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. | Q51187020 |
| | Cerebrospinal fluid (1,3)-β-D-glucan in isolated Candida meningitis. | Q51843383 |
| | The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. | Q52896107 |
| | Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. | Q52926328 |
| | Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. | Q53577661 |
| | Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation. | Q53906312 |
| | Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. | Q53950594 |
| | Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. | Q54047146 |
| | The central nervous system and infection by Candida species | Q33974426 |
| | Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management | Q33974722 |
| | Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. | Q34020746 |
| | Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy | Q34041795 |
| | Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis | Q34115955 |
| | The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. | Q34124520 |
| | Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. | Q34195389 |
| | Assessment of a real-time PCR method to detect human non-cryptococcal fungal meningitis | Q34228957 |
| | Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century | Q34294875 |
| | Posaconazole as salvage therapy for zygomycosis | Q34301611 |
| | Herpes simplex virus-1 encephalitis: a review of current disease management with three case reports | Q34302338 |
| | Central nervous system infections in the compromised host: a diagnostic approach | Q34305112 |
| | Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoter | Q34315804 |
| | Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. | Q34342140 |
| | Epidemiology and outcome of zygomycosis: a review of 929 reported cases | Q34440240 |
| | Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. | Q34451601 |
| | Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center | Q34453311 |
| | Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases | Q34498982 |
| | Epstein-Barr virus infections of the central nervous system. | Q34531289 |
| | Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis | Q34602520 |
| | Bacterial and fungal meningitis in patients with cancer. | Q34762496 |
| | Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation | Q35017153 |
| | Valacyclovir for herpes simplex encephalitis | Q35065826 |
| | Molecular methods to improve diagnosis and identification of mucormycosis | Q35066797 |
| | Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1. | Q35138748 |
| | Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients | Q35157937 |
| | Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan | Q35203120 |
| | Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay | Q35220840 |
| | Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections | Q35483682 |
| | Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient | Q35563801 |
| | The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis | Q35635476 |
| | Future directions in mucormycosis research | Q35672102 |
| | Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics | Q35715674 |
| | Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis | Q35789498 |
| | How I treat mucormycosis | Q35797637 |
| | Candida infection of the central nervous system following neurosurgery: a 12-year review | Q37856812 |
| | Imaging of central nervous system viral diseases | Q37984026 |
| | Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation | Q37984818 |
| | Advances in treatment of bacterial meningitis | Q38058958 |
| | Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases | Q38062286 |
| | Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis | Q38070751 |
| | Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncol | Q38081793 |
| | New approaches to the diagnosis and treatment of cryptococcal meningitis | Q38203205 |
| | Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. | Q38222029 |
| | Isavuconazole treatment of a patient with disseminated mucormycosis | Q38322367 |
| | Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach | Q38362057 |
| | Conventional polymerase chain reaction for the diagnosis of neurotoxoplasmosis: comparison of three sets of primers for the B1 gene using CSF samples. | Q38868363 |
| | Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial | Q38922578 |
| | Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. | Q39123468 |
| | Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. | Q39123475 |
| | Pathology of fungal infections of the central nervous system: 17 years' experience from Southern India | Q39498923 |
| | Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features | Q39523781 |
| | Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis | Q39697409 |
| | Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. | Q40010799 |
| | A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). | Q40016281 |
| | PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients | Q40178743 |
| | Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster | Q40213016 |
| | Herpes simplex virus 2 meningitis: a retrospective cohort study | Q40254534 |
| | Spectrum and prognosis of neurologic complications after hematopoietic transplantation | Q40261856 |
| | Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers | Q40317932 |
| | Severe cerebral toxoplasma infection cannot be excluded by a normal CT scan | Q40384890 |
| | Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature | Q40435312 |
| | A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients | Q40489721 |
| | Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations | Q40520725 |
| | Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection. | Q40529705 |
| | Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus | Q40617934 |
| | International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. | Q40633506 |
| | Candidal meningitis in HIV-infected patients: analysis of 14 cases | Q40646166 |
| | Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review. | Q40647228 |
| | Chronic candidal meningitis: an uncommon manifestation of candidiasis | Q40699217 |
| | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group | Q40738767 |
| | (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients | Q40981795 |
| | Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis? | Q41072169 |
| | Cytomegalovirus encephalitis | Q41117608 |
| | Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia. | Q41666906 |
| | Disseminated mucormycosis in a paediatric patient: Lichthemia corymbifera successfully treated with combination antifungal therapy | Q41671909 |
| | Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients | Q41732115 |
| | Combination antifungal therapy for cryptococcal meningitis | Q41924502 |
| | Late relapse of progressive multifocal leucoencephalopathy postallogenic transplant in a young patient with CLL. | Q42117153 |
| | Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis | Q42131264 |
| | Clinical usefulness of FDG PET/CT in the detection of unusual central nervous system infections | Q42203395 |
| | Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection | Q42222344 |
| | Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology | Q42233832 |
| | Cerebral vasculitis and encephalitis due to Epstein-Barr virus in a patient with newly diagnosed HIV infection | Q42235300 |
| | Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF. | Q42246502 |
| | Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. | Q42251011 |
| | A mucormycosis case treated with a combination of caspofungin and amphotericin B. | Q42255049 |
| | Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: a diagnostic and therapeutic challenge. | Q42271810 |
| | ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. | Q42280429 |
| | The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitis | Q42283610 |
| | Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries. | Q42958723 |
| | Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial | Q42973347 |
| | Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety | Q43035140 |
| | Acyclovir resistance in herpes simplex encephalitis. | Q43047087 |
| | Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae. | Q43189988 |
| | Forty-one recent cases of invasive zygomycosis from a global clinical registry. | Q43223060 |
| | Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). | Q43260620 |
| | Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011. | Q43450116 |
| | Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience | Q43512137 |
| | Intracranial aspergilloma in immunocompetent patients successfully treated with radical surgical intervention and antifungal therapy: case series | Q43643224 |
| | High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial | Q43678311 |
| | Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia | Q43808662 |
| | Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients | Q43843926 |
| | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec | Q43952836 |
| | Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study | Q43971471 |
| | Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients | Q43974785 |
| | Prospective evaluation of neurological complications after allogeneic bone marrow transplantation | Q43994969 |
| | Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients | Q44189602 |
| | Cerebral granuloma and meningitis caused by Candida albicans: useful monitoring of mannan antigen in cerebrospinal fluid | Q44217803 |
| | Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient | Q44297815 |
| | Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome | Q44377391 |
| | Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections | Q44417870 |
| | Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia | Q44494625 |
| | Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients | Q44564506 |
| | Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease | Q44575785 |
| | High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates | Q44589206 |
| | Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model | Q44636233 |
| | Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. | Q44801909 |
| | Clinical characteristics, treatment and prognostic factors of candidal meningitis in a teaching hospital in Taiwan | Q44828144 |
| | The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial | Q44924916 |
| | Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system | Q44988168 |
| | Comparison of real-time florescence quantitative PCR measurements of VAD1 mRNA with three conventional methods in diagnosis and follow-up treatment of Cryptococcus neoformans infection | Q45109393 |
| | Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection | Q45111047 |
| | Herpes simplex virus encephalitis pharmacotherapy: alternative treatment options | Q45323550 |
| | Successful outcome of Epstein-Barr virus encephalitis managed with bilateral craniectomy, corticosteroids and aciclovir | Q45355687 |
| | HSV IgG antibody inhibits virus detection in CSF. | Q45355866 |
| | Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation | Q45363416 |
| | Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case | Q45381944 |
| | Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient | Q45388844 |
| | Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma | Q45420709 |
| | Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation | Q45436289 |
| | Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid. | Q45729136 |
| | Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). | Q37469829 |
| | Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis | Q37475959 |
| | Zygomycosis: conventional laboratory diagnosis | Q37597554 |
| | Human herpesvirus 6 in hematological malignancies. | Q37631313 |
| | CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency | Q37700176 |
| | Refractory candidal meningitis in an immunocompromised patient cured by caspofungin | Q37702851 |
| | Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis | Q37824887 |
| | An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. | Q54105558 |
| | Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis. | Q54443351 |
| | Detection of Cryptococcus by conventional, serological and molecular methods. | Q54477430 |
| | Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae. | Q54671657 |
| | Editorial | Q56569031 |
| | Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults | Q56795495 |
| | A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine | Q58292702 |
| | Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 | Q58405315 |
| | Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid | Q68290293 |
| | 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series | Q70463329 |
| | Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome) | Q71134478 |
| | Chronic meningitis caused by Candida albicans in a liver transplant recipient: usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment | Q71554807 |
| | Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS | Q71608309 |
| | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group | Q71693371 |
| | Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation | Q72095787 |
| | Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study | Q72133325 |
| | Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases | Q73446071 |
| | Successful Use of Cidofovir in Treating AIDS-Related Cytomegalovirus Retinitis, Encephalitis, and Esophagitis | Q73494369 |
| | Evaluation of the Candigen enzyme-linked immunosorbent assay for quantitative detection of Candida species antigen | Q73569749 |
| | Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir | Q73586998 |
| | Use of oral valaciclovir in a 12-year-old boy with herpes simplex encephalitis | Q73740670 |
| | Candida albicans meningitis: clinical case | Q73858147 |
| | In situ hybridization for the identification of filamentous fungi in tissue section | Q74230755 |
| | Liposomal amphotericin B treatment for neonatal fungal infections | Q74287663 |
| | Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia | Q74318228 |
| | The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy | Q79743466 |
| | Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient | Q80109886 |
| | Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient | Q80363310 |
| | Neurocryptococcosis: diagnosis by PCR method | Q80552211 |
| | The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America | Q81530263 |
| | Hyperbaric oxygen as an adjunctive treatment for zygomycosis | Q81870364 |
| | Diagnosis of neurotoxoplasmosis by antibody detection in cerebrospinal (CSF) fluid using Latex Agglutination Test and ELISA | Q82692575 |
| | Central nervous system infections in cancer patients | Q84476095 |
| | Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient | Q85157571 |
| | (1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections | Q86081204 |
| | Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis | Q86221095 |
| | Diagnosis of herpesvirus infections of the central nervous system. | Q35866560 |
| | Varicella zoster virus and central nervous system syndromes | Q35866571 |
| | Utility of Aspergillus antigen detection in specimens other than serum specimens | Q35951605 |
| | Combination therapy for mucormycosis: why, what, and how? | Q35974333 |
| | Diagnosis and management of central nervous system histoplasmosis | Q36056886 |
| | The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial | Q36058200 |
| | Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. | Q36240644 |
| | Activity of posaconazole in the treatment of central nervous system fungal infections | Q36246196 |
| | Management of intracranial fungal infections in patients with haematological malignancies | Q36286439 |
| | Improved survival in central nervous system aspergillosis: a series of immunocompromised children with leukemia undergoing stereotactic resection of aspergillomas. Report of four cases | Q36306540 |
| | Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature | Q36311532 |
| | Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis | Q36328956 |
| | Is combination antiviral therapy for CMV superior to monotherapy? | Q36357633 |
| | Fungal pneumonia due to molds in patients with hematological malignancies | Q36616182 |
| | Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature | Q36672687 |
| | Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant | Q36684086 |
| | Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data | Q36703383 |
| | Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation | Q36727466 |
| | CNS cryptococcosis in AIDS: spectrum of MR findings. | Q36782653 |
| | Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). | Q36862446 |
| | Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr | Q37036246 |
| | Neuropathology of viral infections of the central nervous system | Q37101898 |
| | Central nervous system tuberculosis: pathogenesis and clinical aspects | Q37133651 |
| | Hyperbaric oxygen: applications in infectious disease | Q37136585 |
| | Invasive intracranial aspergillosis: the management dilemmas | Q37142855 |
| | Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis | Q37156934 |
| | Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study | Q37159647 |
| | Imaging findings of rhinocerebral mucormycosis | Q37164337 |
| | Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy | Q37263320 |
| | The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates | Q37320912 |
| | Central nervous system infections in immunocompromised patients: update on diagnostics and therapy | Q37334159 |
| | Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review | Q37404559 |
| | Cerebral aspergillosis: tissue penetration is the key. | Q37405288 |
| P433 | issue | 7 | |
| P921 | main subject | medical oncology | Q6050805 |
| | stem cell transplantation | Q65592366 |
| P304 | page(s) | 1207-1225 | |
| P577 | publication date | 2016-04-06 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). | |
| P478 | volume | 27 | |